| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 09/18/2008 | US20080227204 Nutrient broth comprising fibronectin and CD-3 specific antibody for use as inductive source for propagation of natural killer cells |
| 09/18/2008 | US20080227135 Autoimmune Conditions and NADPH Oxidase Defects |
| 09/18/2008 | US20080227082 Method of identifying a mhc class i restricted t cell response |
| 09/18/2008 | US20080226729 Formed by atomizing liquid formulation comprising immunogen (selected from Botulinum neurotoxin, Bacillus antracis antigen, Staphylococcal enterotoxin, Yersinia pestis antigen) adsorbed onto aluminum adjuvant, freezing, then drying |
| 09/18/2008 | US20080226725 New and Advantageous Hydrogel Composition |
| 09/18/2008 | US20080226718 Indole and Azaindole Derivatives For the Treatment of Inflammatory and Autoimmune Diseases |
| 09/18/2008 | US20080226695 Water degradation; controlled drying; self-supporting edible film; uniform distribution; mixing water soluble polymer with water and active material; deaeration |
| 09/18/2008 | US20080226681 Highly Active Glycoproteins-Process Conditions and an Efficient Method for their Production |
| 09/18/2008 | US20080226679 Novel surface exposed proteins from chlamydia pneumoniae |
| 09/18/2008 | US20080226674 Anticancer drugs encapsulated in and mixed with envelop protein virus vector; intensify immunology response in animals |
| 09/18/2008 | US20080226673 Subunit vaccine against respiratory syncytial virus infection |
| 09/18/2008 | US20080226672 Adjuvant Systems and Vaccines |
| 09/18/2008 | US20080226671 Deactivation or attenuation Mycoplasma vaccine for cattle; side effect reduction; respiratory system disorders ; mammary disorders; joint, eye, ear infections |
| 09/18/2008 | US20080226667 Toll-like receptor modulator for use in prevention and treatment of neurodegenerative disorders |
| 09/18/2008 | US20080226665 EphA2 T-cell epitopes and uses therefor |
| 09/18/2008 | US20080226664 Colon cancer antigen panel |
| 09/18/2008 | US20080226662 Nucleotide sequences coding mammalian immune system modulator (B7-DC) for use in treatment and prevention of viral infcetion a nd cell proliferative disorders; immunotherapy |
| 09/18/2008 | US20080226654 Uses of mammalian cytokine; related reagents |
| 09/18/2008 | US20080226649 Cytosine/guanine nucleotide sequences for use as therapeutic in treatment of allergy, asthma, cancer, infection, anemia, thrombocytopenia and neutropenia. |
| 09/18/2008 | US20080226648 Using cysteamine compound to treat immunological disorders |
| 09/18/2008 | US20080226647 Using interferon gamma receptor 1 (IFNGR1) specific immunoglobulin for diagnosis, prevention and treatment of myxovirus infection |
| 09/18/2008 | US20080226640 Mixture comprising serum complement system protein (INSP162) use in preparation of vaccines and antibodies for treatment and prevention of infcetion, cell proliferative, skin, neurodegenerative, bone, inflammatory, respiratory system and autoimmune disorders |
| 09/18/2008 | US20080226637 Hemophilus polypeptide for generating immunoglobulins and vaccines for use in prevention and treatment of bacterial infection |
| 09/18/2008 | US20080226620 Polypeptide comprising major histocompatibility complex epitopes for use in targeting and destroying tumor cells |
| 09/18/2008 | US20080226607 Polypeptide comprising major histocompatibility complex epitopes for use in targeting and destroying tumor cells |
| 09/18/2008 | US20080226606 Polypeptide comprising major histocompatibility complex epitopes for use in targeting and destroying tumor cells |
| 09/18/2008 | US20080226597 Viricidal protein for prevention and treatment of hepatitis infection |
| 09/18/2008 | US20080226594 Culturing circular ssdna viruses for the production of vaccines |
| 09/18/2008 | US20080226587 Methods and compositions for immunomodulation |
| 09/18/2008 | US20080226583 Therapeutic polyesters and polyamides |
| 09/18/2008 | CA2813040A1 Secreted campylobacter flagella coregulated proteins as immunogens |
| 09/18/2008 | CA2702650A1 Phenyl amino pyrimidine compounds and uses thereof |
| 09/18/2008 | CA2680792A1 Treatment of autoimmune disorders |
| 09/18/2008 | CA2680600A1 Li-rnai involved li suppression in cancer immunotherapy |
| 09/18/2008 | CA2680236A1 Protective agents for transplanted organs |
| 09/18/2008 | CA2679643A1 Procaspase 8-mediated disease targeting |
| 09/18/2008 | CA2679589A1 Method for production of sugar oxazoline derivative |
| 09/18/2008 | CA2679070A1 Oligomer-antihistamine conjugates |
| 09/18/2008 | CA2679050A1 Cytotoxicity mediation of cells evidencing surface expression of cd44 |
| 09/17/2008 | EP1970386A2 Hybrid immunoglobulins |
| 09/17/2008 | EP1970385A2 Tetravalent anti-CD20 and/or anti-CD23 antibodies |
| 09/17/2008 | EP1970373A1 Alicyclic heterocyclic compound |
| 09/17/2008 | EP1970372A2 Salts of 9-oxoacridine-10-acetic acid with 1-alkylamno-1-desoxy-polyols |
| 09/17/2008 | EP1970072A1 Use of GLP-2 peptides for the treatment of hyperparathyroidism |
| 09/17/2008 | EP1970058A1 Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs |
| 09/17/2008 | EP1969951A2 Compositions against inflammatory processes |
| 09/17/2008 | EP1969368A2 Potentiation of apoptosis by monoclonal antibodies |
| 09/17/2008 | EP1969011A1 Preparation useful for, and method for treatment of neonatal alloimmune thrombocytopenia (nait) |
| 09/17/2008 | EP1968937A1 Deazapurine analogs of 1'-aza-l-nucleosides |
| 09/17/2008 | EP1968607A1 Treatment of cancer and other diseases |
| 09/17/2008 | EP1968587A1 Substituted imidazoquinolines, imidazonaphthyridines, and imidazopyridines, compositions, and methods |
| 09/17/2008 | EP1968580A2 2-(ih-thieno [3,2-c] pyrazol-3yl)-ih-indole derivatives and related compounds as tec kinase inhibitors for the treatment of inflammations and immunological disorders |
| 09/17/2008 | EP1968576A1 Mif inhibitors |
| 09/17/2008 | EP1968575A2 Immunomodulatory pharmaceutical composition containing a combination of three coumarinolignoids |
| 09/17/2008 | EP1968564A2 Use of beta-hydroxy-beta-methylbutyrate to modulate the imbalance in type 1 and type 2 cytokine production |
| 09/17/2008 | EP1776356B1 Alkyl-and piperidine-substituted benzimidazole-derivates |
| 09/17/2008 | EP1509543B1 Non-immunosuppressive imunogenic or vaccine composition comprising a mutated e7 protein of the hpv-16 virus |
| 09/17/2008 | EP1495003B1 Fredericamycin derivatives |
| 09/17/2008 | EP1253941B1 Pre-transplant accommodated organs resistant to anti-donor immunity |
| 09/17/2008 | EP1009440B1 Method for inhibiting immunostimulatory dna associated responses |
| 09/17/2008 | CN101268373A TIRC7 as marker for detecting early immune activation |
| 09/17/2008 | CN101268100A Modified leukocyte ig-like receptor family members (LIR'S) with increased affinity for class I MHC and their uses in modulating T cell activation |
| 09/17/2008 | CN101268095A Bifunctional protein anchors |
| 09/17/2008 | CN101268049A Novel piperidine derivatives |
| 09/17/2008 | CN101268046A Carboxamide derivatives as muscarinic receptor antagonists |
| 09/17/2008 | CN101267816A Methods of treatment using hydroquinone ansamycins |
| 09/17/2008 | CN101265302A Panax japonicus polysaccharides, preparation method and use thereof |
| 09/17/2008 | CN101265301A Panax japonicus polysaccharides, preparation method and use thereof |
| 09/17/2008 | CN101265285A Immunostimulatory nucleic acid molecules |
| 09/17/2008 | CN101265250A Substituted flavonoids and preparation method, application and pharmaceutical composition thereof |
| 09/17/2008 | CN101264324A Blocking immune response to a foreign antigen using an antagonist which binds to CD20. |
| 09/17/2008 | CN101264323A Respiratory syncytial virus sub-units vaccine, preparation and application |
| 09/17/2008 | CN101264318A Virosis vaccine oral liquid for livestock, poultry and marine lives animal and preparation thereof |
| 09/17/2008 | CN101264317A Preparation of orally-administered protolysate |
| 09/17/2008 | CN101264316A Preparation of medicinal protolysate |
| 09/17/2008 | CN101264227A Quality control method of í«pingfeng shengmaií» capsule |
| 09/17/2008 | CN101264190A Chinese medicinal composition treating allergic rhinitis and preparation thereof |
| 09/17/2008 | CN101264182A Hemogenesis marrow-benefiting medicine |
| 09/17/2008 | CN101264170A Tianshen oral liquid with fatigue-resistance and immunoregulation action |
| 09/17/2008 | CN101264152A Medicinal composition for treating anorexia and monophagia and preparation thereof |
| 09/17/2008 | CN101264142A Antiphlogistic, pain relieving, spasmolytic and immunoregulation medicaments and preparation |
| 09/17/2008 | CN101264127A Sophora alopecuroids total alkaloid powder injection and preparation thereof |
| 09/17/2008 | CN101264107A Bacillus licheniformis medicinal composition and preparations thereof |
| 09/17/2008 | CN101264069A Application of resveratrol derivative in preparing medicine for treating disease relative to immune |
| 09/17/2008 | CN101264068A Ciclesonide dry powder inhalant and preparation thereof |
| 09/17/2008 | CN101263892A Medlar dietary cure health preserving noodle |
| 09/17/2008 | CN101263855A Honey rose beverage |
| 09/17/2008 | CN101263854A Honey glossy ganoderma tea |
| 09/17/2008 | CN100418950C Process for the manufacture of quinoline derivatives |
| 09/17/2008 | CN100418576C Subcutaneously-administered ganglioside-based vaccine compositions |
| 09/17/2008 | CN100418566C Health-caring essence and preparation method thereof |
| 09/17/2008 | CN100418532C Use of NF-kB inhibitor for treating several diseases |
| 09/16/2008 | US7425610 Expression vector comprising nucleotide sequences coding novel receptor protein for use in prevention and treatment of cell proliferative and autoimmune disorders |
| 09/16/2008 | US7425567 Inhibitor of phosphodiesterase enzyme, 2-(4-(3-cyclopentyloxy-4-difluoromethoxyphenyl)-4-cyanopiperidin-1-yl)acetic acid monohydrate; treating inflammatory diseases, diabetics, allergic diseases, autoimmune diseases, ocular diseases, osteoporosis, Parkinson's disease, dementia; chemical intermediates |
| 09/16/2008 | US7425566 1,3-dihydro-2H-indol-2-one derivatives, process for preparing them and pharmaceutical compositions containing them |
| 09/16/2008 | US7425563 Excellent poly (ADP-ribose) synthetase inhibitors; various ischemic diseases, inflammatory diseases, neurodegenerative diseases, diabetes, septic shock, cephalic injury; 1,2-Dihydro-4-[4-(dimethylaminomethyl)phenyl]-5-hydroxy-1-oxoisoquinoline |
| 09/16/2008 | US7425555 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors |
| 09/16/2008 | US7425554 1,2-di(cyclic)substituted benzene compounds |
| 09/16/2008 | US7425532 Use of alanyl aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors |
| 09/16/2008 | US7425339 for use in immunosuppressive therapy, in particular as inhibitors of cytotoxic T cell responses; for graft versus host disease/autoimmune disorders |